Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-03

FDA Approved: ONAPGO — Original Application (MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved ONAPGO (apomorphine hydrochloride) from MDD US Operations, LLC (a subsidiary of Supernus Pharmaceuticals) under an Original NDA. The approval marks…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONAPGO (APOMORPHINE HYDROCHLORIDE)

Snippet

ORIG AP for ONAPGO (APOMORPHINE HYDROCHLORIDE)